参考文献/References:
[1] 董强,郭起浩,罗本燕,等.卒中后认知障碍管理专家共识[J].中国卒中杂志,2017,12(06):519-531.[2] Carlson MC,Xue QL,Zhou J,et al.Executive decline and dysfunction precedes declines in memory: the Women’s Health and Aging Study II[J].J Gerontol A Biol Sci Med Sci,2009,64(1):110-117.[3] Fukuda M,Yamauchi H,Hitoshi Y,et al.The evaluation of oxidative DNA damage in children with brain damage using 8-hydroxydeoxyguanosine levels[J].Brain and Development,2008,30(2):131-136.[4] Bulzacka E,Boyer L,Schürhoff F,et al.Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset[J].Schizophr Bull,2016,42(5):1290-1302.[5] Liu ZH,Liu YT,Tu XJ,et al.High serum levels of malondialdehyde and 8-OHdG are both associated with early cognitive impairment in patients with acute ischaemic stroke[J].Sci Rep,2017,7(1):9493.[6] Simani L,Ryan F,Hashemifard S,et al.Serum coenzyme Q10 is associated with clinical neurological outcomes in acute stroke patients[J].Journal of Molecular Neuroscience,2018,66(1):53-58.[7] Jorat MV,Tabrizi R,Kolahdooz F,et al.The effects of coenzyme Q10 supplementation on biomarkers of inflammation and oxidative stress in among coronary artery disease: a systematic review and meta-analysis of randomized controlled trials[J].Inflammopharmacology,2019,27(2):233-248.[8] Chen AQ,Arthur EO,Monteiro M,et al.Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias[J].Neurobiol Aging,2016,38:56-67.[9] Kulesh A,Drobakha V,Kuklina E,et al.Cytokine response, Tract-Specific fractional anisotropy, and brain morphometry in Post-Stroke cognitive impairment[J].Journal of Stroke and Cerebrovascular Diseases,2018,27(7):1752-1759.[10] Narasimhalu K,Lee J,Leong YL,et al.Inflammatory markers and their association with post stroke cognitive decline[J].International Journal of Stroke,2015,10(4):513-518.[11] Kuo HK,Yen CJ,Chang CH,et al.Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis[J].The Lancet Neurology,2005,4(6):371-380.[12] Irimie CA,Varciu M,Irimie M,et al.C-Reactive protein and T3: new prognostic factors in acute ischemic stroke[J].J Stroke Cerebrovasc Dis,2018,27(10):2731-2737.[13] Zheng F,Xie WX.High-sensitivity C-reactive protein and cognitive decline: the English Longitudinal Study of Ageing[J].Psychol Med,2018,48(8):1381-1389.[14] Slaven P,Vladimir T,Mutzenbach JS,et al.Fibrinogen consumption is related to intracranial clot burden in acute ischemic stroke: a retrospective hyperdense artery study[J].J Transl Med,2016,14(1):250.[15] Tampubolon G.Repeated systemic inflammation was associated with cognitive deficits in older Britons[J].Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring,2016,3(1):1-6.[16] Liu YT,Chen HJ,Kai Z,et al.High levels of plasma fibrinogen are related to post-stroke cognitive impairment[J].Brain Behav,2019,9(10):e01391.[17] Siuda J,Patalong-Ogiewa M,Zmuda W,et al.Cognitive impairment and BDNF serum levels[J].Neurol Neurochir Pol,2017,51(1):24-32.[18] Guzowski JF,Gregory LL,Stevenson GD,et al.Inhibition of Activity-Dependent arc protein expression in the rat hippocampus impairs the maintenance of Long-Term potentiation and the consolidation of Long-Term memory[J].J Neurosci,2000,20(11):3993-4001.[19] Chen HG,Wang M,Jiao AH,et al.Research on changes in cognitive function,beta-amyloid peptide and neurotrophic factor in stroke patients[J].Eur Rev Med Pharmacol Sci,2018,22(19):6448-6455.[20] Tasneem MH,Isyaku UY.Peripheral brain-derived neurotrophic factor is reduced in stroke survivors with cognitive impairment[J].Pathophysiology,2018,25(4):405-410.[21] Nieto-Estévez V,Defterali ?Vicario-Abejón C.IGF-I: A key growth factor that regulates neurogenesis and synaptogenesis from embryonic to adult stages of the brain[J].Front Neurosci,2016,10:52.[22] De Smedt A,Brouns R,Uyttenboogaart M,et al.Insulin-Like growth factor I serum levels influence ischemic stroke outcome[J].Stroke,2011,42(8):2180-2185.[23] Ploughman M,Eskes GA,Kelly LP,et al.Synergistic benefits of combined aerobic and cognitive training on fluid intelligence and the role of IGF-1 in chronic stroke[J].Neurorehabil Neural Repair,2019,33(3):199-212.[24] Sodergren A,Stegmayr B,Ohman ML,et al.Increased incidence of stroke and impaired prognosis after stroke among patients with seropositive rheumatoid arthritis[J].Clin Exp Rheumatol,2009,27(4):641-644.[25] Kristian PD,Buckwalter MS.Does B lymphocyte-mediated autoimmunity contribute to post-stroke dementia?[J].Brain Behav Immun,2017,64:1-8.[26] Zhu ZB,Zhong CK,Guo DX,et al.Multiple biomarkers covering several pathways improve predictive ability for cognitive impairment among ischemic stroke patients with elevated blood pressure[J].Atherosclerosis,2019,287:30-37.[27] Zhu ZB,Chen LH,Guo DX,et al.Serum rheumatoid factor levels at acute phase of ischemic stroke are associated with poststroke cognitive impairment[J].Journal of Stroke and Cerebrovascular Diseases,2019,28(4):1133-1140.[28] Ji YF,Lyu P,Wei J,et al.Homocysteine: a modifiable culprit of cognitive impairment for us to conquer?[J].J Neurol Sci,2019,404:128-136.[29] Wu JX,Jian X,Lei Z,et al.Plasma parameters and risk factors of patients with post-stroke cognitive impairment[J].Ann Palliat Med,2020,9(1):45-52.[30] Meng HX,Yang L,Wei Z,et al.The relationship between cognitive impairment and homocysteine in a B12 and folate deficient population in China[J].Medicine(Baltimore),2019,98(47):e17970.[31] Vogt NM,Romano KA,Darst BF,et al.The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease[J].Alzheimers Res Ther,2018,10(1):124.[32] Chen Z,Li GZ,Lv ZY,et al.Association of plasma trimethylamine-N-oxide levels with post-stroke cognitive impairment: a 1-year longitudinal study[J].Neurological Sciences,2020,41(1):57-63.[33] Ramani M,Groen TV,Kadish I,et al.Vitamin a and retinoic acid combination attenuates neonatal hyperoxia-induced neurobehavioral impairment in adult mice[J].Neurobiol Learn Mem,2017,141:209-216.[34] Hou L,Ding CX,Zhao C,et al.Serum retinoic acid level and the risk of poststroke cognitive impairment in ischemic stroke patients[J].Journal of Stroke and Cerebrovascular Diseases,2019,28(11):104352.[35] Chen HJ,Wu YM,Huang GQ,et al.Low Tri-iodothyronine Syndrome Is Associated With Cognitive Impairment in Patients With Acute Ischemic Stroke: A Prospective Cohort Study[J].The American Journal of Geriatric Psychiatry,2018,26(12):1222-1230.[36] Mao L,Chen XH,Zhuang JH,et al.Relationship between beta-amyloid protein 1-42,thyoid hormone levels and the risk of cognitive impairment after ischemic stroke[J].Wold J Clin Cases,2020,8(1):76-87.[37] Ghidoni R,Benussi L,Glionna M,et al.Plasma cystatin C and risk of developing Alzheimer’s disease in subjects with mild cognitive impairment[J].J Alzheimers Dis,2010,22(3):985-991.[38] Lars B,Matthew BM,Mullin K,et al.Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database[J].Nat Genet,2007,39(1):17-23.[39] Qiong Z,Huang ZH,Wei L,et al.Correlations of serum cystatin C level and gene polymorphism with vascular cognitive impairment after acute cerebral infarction[J].Neurological Sciences,2019,40(5):1049-1054.[40] Jae-Min K,Robert S,Man-Seok P,et al.Associations of BDNF genotype and promoter methylation with acute and Long-Term stroke outcomes in an East Asian cohort[J].PLoS One,2012,7(12):e51280.[41] Rezaei S,Karim AM,Saberi A,et al.Brain-derived neurotrophic factor(BDNF)Val66Met polymorphism and post-stroke dementia: a hospital-based study from northern Iran[J].Neurological Sciences,2016,37(6):935-942.[42] Kai W,Ying C.The SNP43(G/A)polymorphism in CAPN10 gene confers an increased risk of cognitive impairment in cerebral small vessel disease[J].J Clin Lab Anal,2018,32(9):e22615.[43] Packer AN,Xing Y,Harper SQ,et al.The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in huntington’s disease[J].Journal of Neuroscience,2008,28(53):14341-14346.[44] Mijajlovic MD,Pavlovic A,Brainin M,et al.Post-stroke dementia-a comprehensive review[J].BMC Med,2017,15(1):11.[45] Huang SE,Zhao JP,Huang DX,et al.Serum miR-132 is a risk marker of post-stroke cognitive impairment[J].Neurosci Lett,2016,615:102-106.[46] Kalaria RN,Akinyemi R,Ihara M.Stroke injury,cognitive impairment and vascular dementia[J].Biochim Biophys Acta,2016,1862(5):915-925.